Altshuler Shaham
ONCE

Altshuler Shaham’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Altshuler Shaham’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,076
Closed -$337K – 313
2018
Q2 		$337K Hold
4,076
– – 0.03% 99
2018
Q1 		$271K Sell
4,076
-2,890
-41% -$167K 0.04% 104
2017
Q4 		$358K Buy
+6,966
New +$500K 0.05% 87

Other funds holding ONCE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Altshuler Shaham's ONCE Position: Q3 2018 in Review

Altshuler Shaham sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2018, closing a stake of 4,076 shares — an estimated $337K sold.

Altshuler Shaham first reported a position in ONCE in Q4 2017 and held it in 3 quarters. The position peaked at $358K in Q4 2017. 176 funds tracked by Wall St. Rank hold ONCE as of Q3 2018.

  • Altshuler Shaham reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Altshuler Shaham sold 4,076 Spark Therapeutics, Inc. Common Stock shares in Q3 2018, an estimated $337K.
  • Altshuler Shaham first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • Altshuler Shaham's Spark Therapeutics, Inc. Common Stock position peaked at $358K in Q4 2017.
  • 176 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2018.

Based on Altshuler Shaham's 13F filing for Q3 2018, filed 13 Nov 2018.